• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高度恶性的B细胞淋巴瘤常常缺乏HLA-DR、-DP和-DQ抗原以及相关的恒定链。

B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.

作者信息

Momburg F, Herrmann B, Moldenhauer G, Möller P

机构信息

Institute of Pathology, University of Heidelberg, FRG.

出版信息

Int J Cancer. 1987 Nov 15;40(5):598-603. doi: 10.1002/ijc.2910400504.

DOI:10.1002/ijc.2910400504
PMID:3316049
Abstract

The expression of HLA-DR, HLA-DP and HLA-DQ antigens was studied in an unselected series of 66 B-cell lymphomas by means of immunohistology using monoclonal antibodies against non-polymorphic determinants in a sensitive immunoperoxidase technique. In addition, the expression of the MHC class-II antigen-associated invariant chain (li) was examined. The tumors were classified according to the Kiel classification, 30 being of high-grade and 36 being of low-grade malignancy. Only 6 lymphomas of high-grade and 16 lymphomas of low-grade malignancy showed coordinate strong expression of all HLA class-II antigens and invariant chain as observed in the normal peripheral B cell. Six further tumors of high-grade and 8 tumors of low-grade malignancy contained tumor-cell subsets with reduced expression of one or several of the antigens. Eighteen lymphomas of high-grade and 12 lymphomas of low-grade malignancy contained varying tumor-cell subsets that were negative for HLA-DR, -DP, -DQ and li in a selective or combined manner. Three highly malignant tumors were devoid of all class-II antigens and li; 2 highly malignant tumors expressed invariant chain only. The presence of high-grade malignancy was significantly correlated with the occurrence of tumor cells lacking HLA-DR (p = 0.004), HLA-DP (p = 0.013), HLA-DQ (p = 0.007) or li (p = 0.024).

摘要

采用敏感的免疫过氧化物酶技术,运用针对非多态性决定簇的单克隆抗体,通过免疫组织学方法,对66例未经选择的B细胞淋巴瘤系列进行了HLA - DR、HLA - DP和HLA - DQ抗原表达的研究。此外,还检测了MHCⅡ类抗原相关恒定链(li)的表达。肿瘤根据 Kiel 分类法进行分类,其中30例为高级别恶性肿瘤,36例为低级别恶性肿瘤。只有6例高级别淋巴瘤和16例低级别恶性淋巴瘤表现出如正常外周B细胞中观察到的所有HLAⅡ类抗原和恒定链的协同强表达。另外6例高级别肿瘤和8例低级别恶性肿瘤含有一个或几个抗原表达降低的肿瘤细胞亚群。18例高级别淋巴瘤和12例低级别恶性淋巴瘤含有以选择性或联合方式对HLA - DR、- DP、- DQ和li呈阴性的不同肿瘤细胞亚群。3例高度恶性肿瘤缺乏所有Ⅱ类抗原和恒定链;2例高度恶性肿瘤仅表达恒定链。高级别恶性肿瘤的存在与缺乏HLA - DR(p = 0.004)、HLA - DP(p = 0.013)、HLA - DQ(p = 0.007)或恒定链(p = 0.024)的肿瘤细胞的出现显著相关。

相似文献

1
B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.高度恶性的B细胞淋巴瘤常常缺乏HLA-DR、-DP和-DQ抗原以及相关的恒定链。
Int J Cancer. 1987 Nov 15;40(5):598-603. doi: 10.1002/ijc.2910400504.
2
Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.HLA-DR、HLA-DP、HLA-DQ及相关恒定链(Ii)在正常结直肠黏膜、腺瘤及癌组织中的差异表达
Virchows Arch A Pathol Anat Histopathol. 1988;412(4):315-22. doi: 10.1007/BF00750257.
3
Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.非免疫性人类细胞可在无恒定链的情况下表达MHC II类抗原——对正常及慢性炎症小肠的免疫组织学研究
Clin Exp Immunol. 1988 Jun;72(3):367-72.
4
Differential expression of major histocompatibility complex class II antigens on human keratinocytes.人类角质形成细胞上主要组织相容性复合体II类抗原的差异表达。
J Am Acad Dermatol. 1988 Dec;19(6):1030-7. doi: 10.1016/s0190-9622(88)70268-6.
5
Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.II类抗原在胃癌细胞和胃上皮细胞中的表达及功能:DR、DQ和DP抗原的差异表达
J Natl Cancer Inst. 1987 Nov;79(5):923-32.
6
Correlation of HLA-D/Ii antigen expression in breast carcinoma with local lymphohistiocytic infiltration reveals considerable dysregulation in a subset of tumors.乳腺癌中HLA-D/Ii抗原表达与局部淋巴细胞组织细胞浸润的相关性显示,一部分肿瘤存在明显的失调。
Int J Cancer. 1989 Nov 15;44(5):816-22. doi: 10.1002/ijc.2910440512.
7
Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy.MHC I类抗原表达缺陷在高度恶性的B细胞淋巴瘤中很常见。
Int J Cancer. 1987 Jul 15;40(1):32-9. doi: 10.1002/ijc.2910400107.
8
Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis.
Kidney Int. 1989 Jan;35(1):116-24. doi: 10.1038/ki.1989.16.
9
Distribution of HLA-DR, HLA-DP, HLA-DQ antigens in liver tissue from patients with primary sclerosing cholangitis.
Scand J Gastroenterol. 1990 Jan;25(1):54-8. doi: 10.3109/00365529008999209.
10
Major histocompatibility complex class II antigen expression in B and T cell non-Hodgkin's lymphoma.主要组织相容性复合体II类抗原在B和T细胞非霍奇金淋巴瘤中的表达
J Clin Pathol. 1987 Jan;40(1):34-41. doi: 10.1136/jcp.40.1.34.

引用本文的文献

1
A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization.一种激活诱导胞苷脱氨酶的高免疫球蛋白 M 综合征突变破坏 G-四链体结合和全基因组染色质定位。
Immunity. 2020 Nov 17;53(5):952-970.e11. doi: 10.1016/j.immuni.2020.10.003. Epub 2020 Oct 23.
2
Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin's lymphoma to many other types of solid cancers.选择性高亲和力配体药物SH7139的治疗应用不仅限于非霍奇金淋巴瘤,还扩展到许多其他类型的实体癌。
Oncotarget. 2020 Sep 1;11(35):3315-3349. doi: 10.18632/oncotarget.27709.
3
Antigen processing and immune regulation in the response to tumours.
肿瘤应答中的抗原加工与免疫调节
Immunology. 2017 Jan;150(1):16-24. doi: 10.1111/imm.12675. Epub 2016 Oct 12.
4
HLA class I and II expression in oropharyngeal squamous cell carcinoma in relation to tumor HPV status and clinical outcome.人白细胞抗原I类和II类分子在口咽鳞状细胞癌中的表达与肿瘤人乳头瘤病毒状态及临床结局的关系
PLoS One. 2013 Oct 10;8(10):e77025. doi: 10.1371/journal.pone.0077025. eCollection 2013.
5
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy.在癌症免疫治疗中靶向 MHC Ⅱ类抗原呈递途径。
Oncoimmunology. 2012 Sep 1;1(6):908-916. doi: 10.4161/onci.21205.
6
Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.部分浆细胞分化是弥漫性大 B 细胞淋巴瘤中主要组织相容性复合体 II 类表达丢失的机制。
Blood. 2012 Feb 9;119(6):1459-67. doi: 10.1182/blood-2011-07-363820. Epub 2011 Dec 13.
7
A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.逆转录病毒诱变筛选鉴定出 Cd74 是小鼠 B 淋巴细胞中的常见插入位点,并揭示了一种新型 IFNgamma 诱导型 Cd74 同工型的存在。
Mol Cancer. 2010 Apr 23;9:86. doi: 10.1186/1476-4598-9-86.
8
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials.HLA-DR 表达缺失和免疫母细胞形态预示弥漫性大 B 细胞淋巴瘤不良预后——来自两项前瞻性随机临床试验病例分析。
Haematologica. 2009 Nov;94(11):1569-80. doi: 10.3324/haematol.2009.008862.
9
Microarray analysis of B-cell lymphoma cell lines with the t(14;18).对携带t(14;18)的B细胞淋巴瘤细胞系进行微阵列分析。
J Mol Diagn. 2002 Aug;4(3):123-36. doi: 10.1016/S1525-1578(10)60693-9.
10
Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.主要组织相容性复合体I类和II类抗原在弥漫性大细胞和大细胞免疫母细胞淋巴瘤中的表达。抗原表达与临床结果之间不存在相关性。
Am J Pathol. 1993 Oct;143(4):1086-97.